OPKO Health Inc OPK:NASDAQ

Last Price$1.61NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/06/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$1.60 (1,032)
Ask (Size)$1.67 (20)
Day Low / HighN/A - N/A
Volume3.1 M
 

View Biotechnology IndustryPeer Comparison as of 12/06/2019

 

OPKO Health Inc ( NASDAQ )

Price: $1.61
Change: +0.02 (1.26%)
Volume: 3.1 M
4:00PM ET 12/06/2019
 
 

Rhythm Pharmaceuticals Inc ( NASDAQ )

Price: $24.41
Change: +0.54 (2.26%)
Volume: 272.1 K
4:00PM ET 12/06/2019
 
 

Fate Therapeutics Inc ( NASDAQ )

Price: $13.67
Change: +0.10 (0.74%)
Volume: 1.2 M
4:00PM ET 12/06/2019
 
 

Spectrum Pharmaceuticals Inc ( NASDAQ )

Price: $9.84
Change: +0.34 (3.58%)
Volume: 1.4 M
4:00PM ET 12/06/2019
 
 

Karyopharm Therapeutics Inc ( NASDAQ )

Price: $16.29
Change: -1.16 (6.65%)
Volume: 2.8 M
4:00PM ET 12/06/2019
 

Read more news Recent News

Insider Trends: Insider Purchase Adds to OPKO Health Positive Trend
6:47AM ET 11/27/2019 MT Newswires

On Nov 26, 2019, Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, reported a purchase of 100,000 shares in OPKO Health (OPK) for $154,500. ...

Analyst Actions: Piper Jaffray Initiates Coverage on Opko Health With Overweight Rating, $2.50 Price Target
8:42AM ET 11/25/2019 MT Newswires

Opko Health's (OPK) average rating among analysts is a buy, with an average price target of $3. Price: 1.6500, Change: +0.04, Percent Change: +2.48 ...

Insider Trends: Insider Purchase of OPKO Health Stock Extends 90-Day Positive Trend
6:56AM ET 11/20/2019 MT Newswires

On Nov 19, 2019, 10% Owner, Director and CEO & Chairman, Dr Phillip Frost, reported a purchase of 100,000 shares in OPKO Health (OPK) for $146,651. After...

Insider Trends: Insider Buying Continued with Purchase of OPKO Health Stock
6:24AM ET 11/19/2019 MT Newswires

On Nov 18, 2019, 10% Owner, Director and CEO & Chairman, Dr Phillip Frost, made a purchase of 100,000 shares in OPKO Health (OPK) for $147,925. Subsequent...

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Phone+1.305.575.4100
Number of Employees5,690
Recent SEC Filing12/06/20194
Chairman & Chief Executive OfficerPhillip Frost
Vice Chairman & Chief Technical OfficerJane H. Hsiao
Director & Executive Vice President-AdministrationSteven D. Rubin
Chief Executive Officer-OPKO RenalCharles W. Bishop

Company Highlights

Price Open$1.62
Previous Close$1.59
52 Week Range$1.33 - 3.94
Market Capitalization$1.1 B
Shares Outstanding665.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/26/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.48
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-30.98%
Return on Equity-16.14%

Analyst Ratings as of 11/22/2019

Buy
4
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset